Lucienne Chetanoud

A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma.

P. Rouanet, P. Fumoleau, J. Chatal, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.